ArticleEuropean journal of medicinal chemistry2017

Selective HDAC inhibitors with potent oral activity against leukemia and colorectal cancer: Design, structure-activity relationship and anti-tumor activity study.

Xiaoyang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.